Novartis AGNVSNYSE
Loading
Income Before Tax Over TimeExpanding
Percentile Rank93
3Y CAGR+31.8%
5Y CAGR+10.7%
Year-over-Year Change
Pre-tax earnings
3Y CAGR
+31.8%/yr
vs -15.5%/yr prior
5Y CAGR
+10.7%/yr
Recent acceleration
Acceleration
+47.3pp
Accelerating
Percentile
P93
Near historical high
vs 5Y Ago
1.7x
Solid growth
Streak
3 yr
Consecutive growthExpanding
| Period | Value | YoY Change |
|---|---|---|
| 2025 | $16.44B | +20.5% |
| 2024 | $13.64B | +49.5% |
| 2023 | $9.12B | +27.1% |
| 2022 | $7.18B | -70.7% |
| 2021 | $24.53B | +148.3% |
| 2020 | $9.88B | +10.5% |
| 2019 | $8.94B | -36.6% |
| 2018 | $14.10B | +54.9% |
| 2017 | $9.10B | +16.4% |
| 2016 | $7.82B | - |